![PRD_001075 PRD_001075](https://data.pdbj.org/pdbjplus/data/cc/svg/P3N.svg) | PRD_001075 | Name: | N-[(2S)-3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-1-({(2S)-1-[(4-methylbenzyl)amino]-1-oxo-4-phenylbutan-2-yl}amino)-1-oxopropan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide | Formula: | C32 H38 N6 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000330 PRD_000330](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000330.svg) | PRD_000330 | Name: | (5S,8R,11S)-8-(2-carboxyethyl)-5-(carboxymethyl)-14-(4-ethoxy-4-oxobutanoyl)-11-(1-methylethyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13,14-pentaazahexadecan-16-oic acid | Formula: | C30 H41 N5 O14 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000332 PRD_000332](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000332.svg) | PRD_000332 | Name: | Cbz-Asp-Glu-Val-AAsp-CHCH-CON(CH3)CH2Ph | Formula: | C36 H46 N6 O13 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001107 PRD_001107](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001107.svg) | PRD_001107 | Name: | Polyphemusin analog, CXC chemokine receptor antagonist | Formula: | C95 H147 N32 O21 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001125 PRD_001125](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001125.svg) | PRD_001125 | Name: | Peptide ligand | Formula: | C51 H75 N9 O14 | Definition date: | 2013-12-04 | Last modified: | 2023-11-03 |
|
![PRD_001157 PRD_001157](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001157.svg) | PRD_001157 | Name: | Ser-Leu-Phe-His-Phenylalanyl-reduced-peptide-bond-Tyrosyl-Thr-Pro | Formula: | C51 H69 N10 O11 | Definition date: | 2014-01-15 | Last modified: | 2023-11-03 |
|
![PRD_000377 PRD_000377](https://data.pdbj.org/pdbjplus/data/cc/svg/0ZJ.svg) | PRD_000377 | Name: | N-(sulfanylacetyl)-D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide | Formula: | C23 H36 Cl N6 O4 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000387 PRD_000387](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000387.svg) | PRD_000387 | Name: | N-(tert-butoxycarbonyl)-L-alanyl-L-alanyl-N-{(1R)-1-[(S)-[(1S)-2-{[(1R)-1-carboxyethyl]amino}-1-methyl-2-oxoethoxy](hydroxy)phosphoryl]-2-methylpropyl}-L-prolinamide | Formula: | C26 H46 N5 O11 P | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000395 PRD_000395](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000395.svg) | PRD_000395 | Name: | ACE-HAC-ARG-MAA-HAQ-SEL | Formula: | C37 H58 N9 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001184 PRD_001184](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001184.svg) | PRD_001184 | Name: | Dimethyl FK228 | Formula: | C26 H42 N4 O6 S2 | Description: | DIMETHYL FK228 IS THE REDUCED AND MODIFIED FORM OF ROMIDEPSIN. THE DISULFIDE INTRAMOLECULAR LINKAGE OF ROMIDEPSIN IS BROKEN, AND BOTH SULFHYDRYL GROUPS ARE METHYLATED. | Definition date: | 2014-03-05 | Last modified: | 2023-11-03 |
|
![PRD_001189 PRD_001189](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001189.svg) | PRD_001189 | Name: | ATSP-7041 stapled-peptide | Formula: | C87 H124 N16 O22 | Definition date: | 2013-11-20 | Last modified: | 2023-11-03 |
|
![PRD_001198 PRD_001198](https://data.pdbj.org/pdbjplus/data/cc/svg/3VH.svg) | PRD_001198 | Name: |
(3aR,5aS,8S,10aS)-1-[(3S,6R,8aS)-1'-[(2S)-2-acetamido-3-(2-chlorophenyl)propanoyl]-5-oxidanylidene-spiro[1,2,3,8a-tetrahydroindolizine-6,2'-pyrrolidine]-3-yl]carbonyl-10-oxidanylidene-2,3,3a,5a,8,10a-hexahydrodipyrrolo[3,2-b:3',1'-f]azepine-8-carboxylic acid | Formula: | C35 H38 Cl N5 O7 | Definition date: | 2014-10-15 | Last modified: | 2023-11-03 |
|
![PRD_001201 PRD_001201](https://data.pdbj.org/pdbjplus/data/cc/svg/2L0.svg) | PRD_001201 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-leucinamide | Formula: | C29 H49 N3 O6 | Definition date: | 2014-02-12 | Last modified: | 2023-11-03 |
|
![PRD_001215 PRD_001215](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001215.svg) | PRD_001215 | Name: | Macrocyclic Inhibitor (3R,6S,9S,12E,16S)-9-(3-AMINO-3-OXO-PROPYL)-3-[(4-BENZOYLPHENYL)METHYL]-6-(CYCLOHEXYLMETHYL)-2,5,8,11,14-PENTAOXO-1,4,7,10,15-PENTAZACYCLOICOS-12-ENE-16-CARBOXAMIDE | Formula: | C40 H48 N7 O9 | Definition date: | 2014-05-21 | Last modified: | 2023-11-03 |
|
![PRD_000428 PRD_000428](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000428.svg) | PRD_000428 | Name: | CYCLOTHEONAMIDE A | Formula: | C36 H46 N9 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000456 PRD_000456](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000456.svg) | PRD_000456 | Formula: | C39 H67 N12 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000464 PRD_000464](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000464.svg) | PRD_000464 | Name: | Argadin | Formula: | C29 H41 N10 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001233 PRD_001233](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001233.svg) | PRD_001233 | Name: | cyclic-tris-phenylselenazole | Formula: | C36 H30 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
![PRD_001234 PRD_001234](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001234.svg) | PRD_001234 | Name: | cyclic-tris-leucylselenazole | Formula: | C27 H36 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
![PRD_001235 PRD_001235](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001235.svg) | PRD_001235 | Name: | cyclic-tris-valinylselenazole | Formula: | C24 H30 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
![PRD_001236 PRD_001236](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001236.svg) | PRD_001236 | Name: | cyclic-tris-alanylselenazole | Formula: | C18 H18 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
![PRD_001237 PRD_001237](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001237.svg) | PRD_001237 | Name: | Boc-Ala-Ala-Ala-Al-CHO | Formula: | C14 H27 N3 O5 | Definition date: | 2014-06-18 | Last modified: | 2023-11-03 |
|
![PRD_001243 PRD_001243](https://data.pdbj.org/pdbjplus/data/cc/svg/3BV.svg) | PRD_001243 | Name: | N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-phenylalaninamide | Formula: | C40 H61 N5 O7 | Definition date: | 2015-02-04 | Last modified: | 2023-11-03 |
|
![PRD_001255 PRD_001255](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001255.svg) | PRD_001255 | Name: | Promothiocin A | Formula: | C36 H47 N11 O8 S2 | Definition date: | 2014-12-10 | Last modified: | 2023-11-03 |
|
![PRD_000553 PRD_000553](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000553.svg) | PRD_000553 | Name: | APSTATIN | Formula: | C23 H33 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|